CFG
NWBO

Citizens Financial Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Citizens Financial Group’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-625
Closed – – 935
2019
Q2 		$0 Buy
+625
New – ﹤0.01% 878

Other funds holding NWBO

WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Citizens Financial Group's NWBO Position: Q3 2019 in Review

Citizens Financial Group sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q3 2019, closing a stake of 625 shares.

Citizens Financial Group first reported a position in NWBO in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 5 funds tracked by Wall St. Rank hold NWBO as of Q3 2019.

  • Citizens Financial Group reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q3 2019 after selling out during the quarter.
  • Citizens Financial Group sold 625 Northwest Biotherapeutics, Inc. Common stock shares in Q3 2019.
  • Citizens Financial Group first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2019 and held it in 1 quarter.
  • Citizens Financial Group's Northwest Biotherapeutics, Inc. Common stock position peaked at $0 in Q2 2019.
  • 5 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q3 2019.

Based on Citizens Financial Group's 13F filing for Q3 2019, filed 1 Nov 2019.